Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Mustofa Ahda, Irwandi Jaswir, Alfi Khatib, Qamar Uddin Ahmed, Nurkhasanah Mahfudh & Yunita Dewi Ardini. (2023) A review on selected herbal plants as alternative anti-diabetes drugs: chemical compositions, mechanisms of action, and clinical study. International Journal of Food Properties 26:1, pages 1414-1425.
Read now
Read now
Zheng Li, Zongtao Zhou & Luyong Zhang. (2020) Current status of GPR40/FFAR1 modulators in medicinal chemistry (2016–2019): a patent review. Expert Opinion on Therapeutic Patents 30:1, pages 27-38.
Read now
Read now
Hélène G. Bazin, Laura S. Bess & Mark T. Livesay. (2018) Synthesis and Applications of Imidazoquinolines: A Review. Organic Preparations and Procedures International 50:2, pages 109-244.
Read now
Read now
Ozra Tabatabaei-Malazy, Shekoufeh Nikfar, Bagher Larijani & Mohammad Abdollahi. (2016) Drugs for the treatment of pediatric type 2 diabetes mellitus and related co-morbidities. Expert Opinion on Pharmacotherapy 17:18, pages 2449-2460.
Read now
Read now
David R Janero. (2014) Synthetic agents in the context of metabolic/bariatric surgery: expanding the scope and impact of diabetes drug discovery. Expert Opinion on Drug Discovery 9:3, pages 221-228.
Read now
Read now
Articles from other publishers (29)
Nayomi Deshani De Silva, Anoja Priyadarshani Attanayake, Desiree Nedra Karunaratne, Liyanage Dona Ashanti Menuka Arawwawala & Geethi Kaushalya Pamunuwa. (2023)
Synthesis and bioactivity assessment of
Coccinia grandis
L. extract encapsulated alginate nanoparticles as an antidiabetic drug lead
. Journal of Microencapsulation, pages 1-21.
Crossref
Crossref
Dapinder Pal Singh Loona, Bhanuranjan Das, Ramandeep Kaur, Rajnish Kumar & Ashok Kumar Yadav. (2023) Free Fatty Acid Receptors (FFARs): Emerging Therapeutic Targets
for the Management of Diabetes Mellitus. Current Medicinal Chemistry 30:30, pages 3404-3440.
Crossref
Crossref
Zhen Yang, Yiwei Luo, Xiaoyu Xia, Jinzhi He, Jiajia Zhang, Qiwei Zeng, Dong Li, Bi Ma, Shaoyu Zhang, Changxin Zhai, Miao Chen & Ningjia He. (2023) Dehydrogenase MnGutB1 catalyzes 1-deoxynojirimycin biosynthesis in mulberry. Plant Physiology 192:2, pages 1307-1320.
Crossref
Crossref
Anshul Kaushik, Rimjhim Sangtani, Hamendra Singh Parmar & Kiran Bala. (2023) Algal metabolites: Paving the way towards new generation antidiabetic therapeutics. Algal Research 69, pages 102904.
Crossref
Crossref
Aderonke Ibidunni Olagunju, Titilope Ifeolu Arigbede, Solomon Akinremi Makanjuola & Esther Taiwo Oyebode. (2022) Nutritional compositions, bioactive properties, and in-vivo glycemic indices of amaranth-based optimized multigrain snack bar products. Measurement: Food 7, pages 100039.
Crossref
Crossref
Kyriaki Karavanaki, Stavroula A. Paschou, Nicholas Tentolouris, Foteini Karachaliou & Alexandra Soldatou. (2022) Type 2 diabetes in children and adolescents: distinct characteristics and evidence-based management. Endocrine 78:2, pages 280-295.
Crossref
Crossref
Bashir Lawal, Saidu Sani, Amos S. Onikanni, Yunusa O. Ibrahim, Abdulhakeem R. Agboola, Halimat Yusuf Lukman, Femi Olawale, Ali A. Jigam, Gaber El-Saber Batiha, Shukurat B. Babalola, Gomaa Mostafa-Hedeab, Clara Mariana Gonçalves Lima, Alexander T.H. Wu, Hsu-Shan Huang & Carlos Adam Conte-Junior. (2022) Preclinical anti-inflammatory and antioxidant effects of Azanza garckeana in STZ-induced glycemic-impaired rats, and pharmacoinformatics of it major phytoconstituents. Biomedicine & Pharmacotherapy 152, pages 113196.
Crossref
Crossref
Arpita Arora, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Sridevi Chigurupati, Rajwinder Kaur, Saurabh Bhatia, Ahmed Al-Harrasi, Celia Vargas-De-La-Cruz & Simona Bungau. (2021) Free fatty acid receptor 1: a ray of hope in the therapy of type 2 diabetes mellitus. Inflammopharmacology 29:6, pages 1625-1639.
Crossref
Crossref
Anna K. Żołnierczyk, Sylwia Ciałek, Marzena Styczyńska & Maciej Oziembłowski. (2021) Functional Properties of Fruits of Common Medlar (Mespilus germanica L.) Extract. Applied Sciences 11:16, pages 7528.
Crossref
Crossref
Jeremiah Oshiomame Unuofin & Sogolo Lucky Lebelo. (2021) UHPLC-QToF-MS characterization of bioactive metabolites from Quercus robur L. grown in South Africa for antioxidant and antidiabetic properties. Arabian Journal of Chemistry 14:3, pages 102970.
Crossref
Crossref
Elix Alberto Domínguez-Mendoza, Yelzyn Galván-Ciprés, Josué Martínez-Miranda, Cristian Miranda-González, Blanca Colín-Lozano, Emanuel Hernández-Núñez, Gloria I. Hernández-Bolio, Oscar Palomino-Hernández & Gabriel Navarrete-Vazquez. (2021) Design, Synthesis, and In Silico Multitarget Pharmacological Simulations of Acid Bioisosteres with a Validated In Vivo Antihyperglycemic Effect. Molecules 26:4, pages 799.
Crossref
Crossref
Heli Siti Halimatul Munawaroh, Gun Gun Gumilar, Fina Nurjanah, Galuh Yuliani, Siti Aisyah, Dewi Kurnia, Asri Peni Wulandari, Isman Kurniawan, Andriati Ningrum, Apurav Krishna Koyande & Pau-Loke Show. (2020) In-vitro molecular docking analysis of microalgae extracted phycocyanin as an anti-diabetic candidate. Biochemical Engineering Journal 161, pages 107666.
Crossref
Crossref
Xinye Wang, Yi Yang, Yitian Xu, Qian Chen, Hongmei Wang & Huafang Gao. (2020) Predicting hypoglycemic drugs of type 2 diabetes based on weighted rank support vector machine. Knowledge-Based Systems 197, pages 105868.
Crossref
Crossref
Sergey O. Kuranov, Olga A. Luzina, Oleksandra Onopchenko, Iryna Pishel, Sergey Zozulya, Maxim Gureev, Nariman F. Salakhutdinov & Mikhail Krasavin. (2020) Exploring bulky natural and natural-like periphery in the design of p-(benzyloxy)phenylpropionic acid agonists of free fatty acid receptor 1 (GPR40). Bioorganic Chemistry 99, pages 103830.
Crossref
Crossref
Zheng Li, Chunxia Liu, Zongtao Zhou, Lijun Hu, Liming Deng, Qiang Ren & Hai Qian. (2020) A novel FFA1 agonist, CPU025, improves glucose-lipid metabolism and alleviates fatty liver in obese-diabetic (ob/ob) mice. Pharmacological Research 153, pages 104679.
Crossref
Crossref
Dongdong Wang, Elke Heiss, Karel Šmejkal & Atanas G. Atanasov. (2019) Bioactive Molecules and Their Mechanisms of Action. Molecules 24:20, pages 3752.
Crossref
Crossref
Olajumoke A. Oyebode, Ochuko L. Erukainure, Neil A. Koorbanally & Md. Shahidul Islam. (2018) Acalypha Wilkesiana ‘Java White’: Identification of Some Bioactive Compounds by Gc-Ms and Their Effects on Key Enzymes Linked to Type 2 Diabete. Acta Pharmaceutica 68:4, pages 425-439.
Crossref
Crossref
María José Ojeda-Montes, Aleix Gimeno, Sarah Tomas-Hernández, Adrià Cereto-Massagué, Raúl Beltrán-Debón, Cristina Valls, Miquel Mulero, Gerard Pujadas & Santiago Garcia-Vallvé. (2018) Activity and selectivity cliffs for DPP-IV inhibitors: Lessons we can learn from SAR studies and their application to virtual screening. Medicinal Research Reviews 38:6, pages 1874-1915.
Crossref
Crossref
Zheng Li, Xue Xu, Wenlong Huang & Hai Qian. (2018) Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges. Medicinal Research Reviews 38:2, pages 381-425.
Crossref
Crossref
Marie Sarabia-Sánchez, Pedro Trejo-Soto, José Velázquez-López, Carlos Carvente-García, Rafael Castillo, Alicia Hernández-Campos, Claudia Avitia-Domínguez, Daniel Enríquez-Mendiola, Erick Sierra-Campos, Mónica Valdez-Solana, José Salas-Pacheco & Alfredo Téllez-Valencia. (2017) Novel Mixed-Type Inhibitors of Protein Tyrosine Phosphatase 1B. Kinetic and Computational Studies. Molecules 22:12, pages 2262.
Crossref
Crossref
Shao-Lian Wang, Wen-Bin Dong, Xiao-Lin Dong, Wen-Min Zhu, Fang-Fang Wang, Fang Han & Xin Yan. (2017) Comparison of twelve single-drug regimens for the treatment of type 2 diabetes mellitus. Oncotarget 8:42, pages 72700-72713.
Crossref
Crossref
Zheng Li, Chunxia Liu, Xue Xu, Qianqian Qiu, Xin Su, Yuxuan Dai, Jianyong Yang, Huilan Li, Wei Shi, Chen Liao, Miaobo Pan, Wenlong Huang & Hai Qian. (2017) Discovery of phenylsulfonyl acetic acid derivatives with improved efficacy and safety as potent free fatty acid receptor 1 agonists for the treatment of type 2 diabetes. European Journal of Medicinal Chemistry 138, pages 458-479.
Crossref
Crossref
Musri Musman, Safrida Safrida, Viqqi Kurnianda & Erlidawati Erlidawati. (2017) Evaluation of Antihyperglycemic Property from Syzygium oleana (Magnoliopsida: Myrtaceae) Pericarp. Research Journal of Medicinal Plants 11:3, pages 100-106.
Crossref
Crossref
I. Mohanram & J.S. Meshram. 2017. Discovery and Development of Antidiabetic Agents from Natural Products. Discovery and Development of Antidiabetic Agents from Natural Products
271
303
.
Mohammad Hosein Farzaei, Roja Rahimi, Fatemeh Farzaei & Mohammad Abdollahi. (2015) Traditional Medicinal Herbs for the Management of Diabetes and its Complications: An Evidence-Based Review. International Journal of Pharmacology 11:7, pages 874-887.
Crossref
Crossref
Suren A. Tatulian. (2015) Structural Dynamics of Insulin Receptor and Transmembrane Signaling. Biochemistry 54:36, pages 5523-5532.
Crossref
Crossref
Kuruva Chandra Sekhar, Rasheed Syed, Madhava Golla, Jyothi Kumar MV, Nanda Kumar Yellapu, Appa Rao Chippada & Naga Raju Chamarthi. (2014) Novel heteroaryl phosphonicdiamides PTPs inhibitors as anti-hyperglycemic agents. DARU Journal of Pharmaceutical Sciences 22:1.
Crossref
Crossref
Eunsoo Jung, Junghyun Kim, Sung Ho Kim, Sanghwa Kim & Myung-Haing Cho. (2014) Gemigliptin, a novel dipeptidyl peptidase-4 inhibitor, exhibits potent anti-glycation properties in vitro and in vivo. European Journal of Pharmacology 744, pages 98-102.
Crossref
Crossref
Chae-Young Bang & Se-Young Choung. (2014)
Enzogenol improves diabetes-related metabolic change in C57BL/KsJ-
db/db
mice, a model of type 2 diabetes mellitus
. Journal of Pharmacy and Pharmacology 66:6, pages 875-885.
Crossref
Crossref